Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
75%(3 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_2
1
10%
Ph phase_4
3
30%
Ph early_phase_1
1
10%
Ph not_applicable
4
40%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated2
Recruiting1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 43 (33.3%)
N/A4 (44.4%)

Trials by Status

recruiting111%
completed444%
terminated222%
enrolling_by_invitation111%
unknown111%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10